Showing results (31-40 of 332) with videos related to
Sort By:
Pageof 34
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2014
Continuous reduced nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a single-institution's three decade experienceFlorent Malard, Patrice Chevallier, Thierry Guillaume, et al.Human Immunology|April 17, 2012
Investigation of the impact of HLA-DPB1 matching status in 10/10 HLA matched unrelated hematopoietic stem cell transplantation: results of a French single center studyCyrille Touzeau, Katia Gagne, Véronique Sébille, et al.Cytotherapy|February 4, 2018
The doubling potential of T lymphocytes allows clinical-grade production of a bank of genetically modified monoclonal T-cell populationsRégine Vivien, Soraya Saïagh, Philippe Lemarre, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 28, 2016
Higher Early Monocyte and Total Lymphocyte Counts Are Associated with Better Overall Survival after Standard Total Body Irradiation, Cyclophosphamide, and Fludarabine Reduced-Intensity Conditioning Double Umbilical Cord Blood Allogeneic Stem Cell Transplantation in AdultsAmandine Le Bourgeois, Pierre Peterlin, Thierry Guillaume, et al.Journal of Leukocyte Biology|November 26, 2014
Involvement of the CX3CL1 (fractalkine)/CX3CR1 pathway in the pathogenesis of acute graft-versus-host diseaseEolia Brissot, Celine Bossard, Florent Malard, et al.Clinical Immunology (Orlando, Fla.)|February 16, 2010
Shaping of iNKT cell repertoire after unrelated cord blood transplantationVivien Beziat, Stéphanie Nguyen, Mark Exley, et al.Journal of Leukocyte Biology|August 31, 2013
Increased plasmacytoid dendritic cells and RORγt-expressing immune effectors in cutaneous acute graft-versus-host diseaseFlorent Malard, Céline Bossard, Eolia Brissot, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention requiredStéphane Vigouroux, Odile Morin, Philippe Moreau, et al.Bulletin Du Cancer|April 17, 2024
[Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Tamim Alsuliman, Clotilde Aubrun, Jacques Olivier Bay, et al.Leukemia Research|December 17, 2011
Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: a pilot seriesPatrice Chevallier, Arnaud Pigneux, Nelly Robillard, et al.Pageof 34